This Subcontract opportunity from Department Of Defense was posted on December 5, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Safety and Pharmacokinetics Clinical Study (U.S. Site)

Closed

Federal

Submission Closed12/11/2025, 11:00:00 AM EST

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541711

New

Federal

MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORYThe Department of Energy, through the Golden Field Office, is forecasting a contract to manage and operate the National Renewable Energy Laboratory located in Colorado. This initiative falls under NAICS code 541711 and is currently associated with the incumbent contractor, Alliance for Energy Innovation, LLC. The opportunity is listed as a forecast with a posted date of November 8, 2026. Interested parties may coordinate with Yolanda Dixon, the Small Business Program Manager, regarding this requirement.

POSTED

DEADLINE

Research Subaward / Collaborative Research PartnerThis subcontract establishes a collaborative research partnership to support prime contractors on research projects funded by the National Science Foundation and UK Research and Innovation, specifically under the Arts and Humanities Research Council. The selected partner is responsible for executing specialized research tasks, including data collection and analysis, following project-defined methodologies to solve specific research challenges and support planned outputs. Key deliverables include the provision of research data, detailed analysis reports, and contributions to final publications. To ensure compliance, all work must adhere to the NSF Grant Policy Manual and established UKRI funding norms. The engagement is categorized under NAICS code 541711, focusing on research and experimental development in the natural sciences and engineering.

Arts and Humanities Research Council (AHRC)

POSTED

DEADLINE

Novel In-Situ Binder Chemistry DevelopmentThe NASA SBIR/STTR Program is seeking a subcontractor for the development of a novel in-situ binder chemistry designed for use on the Moon or Mars. The primary objective of this project is to create a binder sourced entirely from lunar or Martian regolith that can cure without the need for external energy input. The scope of work encompasses the initial formulation, lab-scale testing, and subsequent optimization of the chemistry to ensure viability for extraterrestrial construction. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, specifically for firms with fewer than 500 employees. The work will be performed at the Kennedy Space Center, falling under NAICS code 541711 for research and development in biotechnology. The solicitation was posted on August 20, 2026, as part of NASA's efforts to advance sustainable infrastructure capabilities for deep space exploration.

NASA SBIR/STTR Program

POSTED

DEADLINE

High-Throughput Serology Assay DevelopmentThe contract requires the design, validation, and delivery of a high-throughput serology platform intended to match or surpass the performance of the current hemagglutination inhibition (HAI) assay used for influenza surveillance. The platform must be scalable and robust enough to support large-scale, rapid serological testing, ensuring accurate and consistent data collection for public health monitoring. Development must adhere to stringent performance benchmarks, with a focus on improving throughput, precision, and reproducibility across diverse influenza strains and sample types. This is a subcontract under the Department of Defense’s FA9000 AFGPO program, with performance centered at DWG. The North American Industry Classification System code 541711 indicates it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 15, 2026, and the work is expected to advance the DoD’s capability in infectious disease surveillance by replacing aging laboratory methods with a next-generation automated system. While no set-aside or point of contact details are provided, the project’s success is critical to maintaining national-level preparedness for seasonal and pandemic influenza threats.

POSTED

DEADLINE

Engineering & Scientific Research SupportThe contract entails providing engineering analysis, research and development, and technical support specifically focused on F-15 aircraft systems, encompassing avionics, propulsion, and weapons integration. The work involves activities such as modeling, simulation, and the formulation of test plans to support enhancements and maintenance of these complex systems. Issued by the Department of Defense under the NAICS code 541711, this subcontract titled "Engineering & Scientific Research Support" is designed to advance the technical capabilities and reliability of the F-15 platform. While certain logistical details like the exact place of performance and point of contact are not specified, the contract underscores a commitment to rigorous scientific and engineering efforts to ensure mission readiness and technological superiority for this key military asset.

FA8622 Aflcmc Azs Epass

POSTED

DEADLINE

Technical Research and Analysis (Science & Technology Focus)This contract involves conducting advanced technical research across physical, engineering, and life sciences disciplines to support innovation and technology development within the defense sector. It is a subcontract opportunity issued by the Department of Defense through Washington Headquarters Services, aimed at advancing scientific and technological capabilities that bolster defense-related projects and initiatives. Designated as a Total Small Business Set-Aside under SBA regulations, the contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. The work is to be performed in Washington, reflecting a focus on high-impact, cutting-edge research that addresses critical defense challenges. This opportunity emphasizes the Department of Defense's commitment to engaging small businesses in strategic research efforts that drive forward defense technology and innovation.

Washington Headquarters Services

POSTED

DEADLINE

Vehicle Recompete: IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR… — INDEFINITE DELIVERY / INDEFINITE QUANTITY NIHNINDS1601This Indefinite Delivery/Indefinite Quantity parent award supports the Pharmacology and Toxicology for Therapeutics Program under the National Institutes of Health. The vehicle, identified by solicitation NIHNINDS1601, has an ordering period that extends through September 12, 2027. It is currently classified as a full recompete and is associated with two primary awards, HHSN271201600006I and HHSN271201600007I. There are currently 18 active task orders with a total combined value of over 18.7 million dollars. SRI International is the dominant incumbent, holding 15 orders totaling approximately 17.1 million dollars, with significant funding dedicated to continuous rodent and non-rodent pharmacokinetic assessments and GLP toxicology studies. Southern Research Institute holds the remaining three orders, valued at approximately 1.66 million dollars.

National Institutes of Health

POSTED

8 months ago

DEADLINE

N/A

AI Contract Overview

This subcontract, issued by the Army Medical Resources Acq Activity under the Department of Defense, involves the execution of a U.S.-based Phase I/II clinical study. The primary objective is to evaluate the safety, pharmacokinetics, and pharmacogenomics of tafenquine. The scope of work includes critical clinical operations such as subject enrollment, administration of dosing, blood sampling, and comprehensive safety follow-up procedures. The project will be performed in Silver Spring, Maryland, under NAICS code 541711. Interested parties must note the tight response window, with the opportunity posted on December 5, 2025, and a response deadline of December 11, 2025.

General Info

Agency

Department Of Defense → Army Medical Resources Acq Activity

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Silver Spring, MD, 20910, USA

Set-Aside

NONE

Documents

This scope was carved out of HT942526Q0025.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Water For Injection (WFI) System Pump repair/replacement and Emergency Services

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedDec 5

subcontract

Response DeadlineDec 11

Deadline has passed

Submission Closed

12/11/2025, 11:00:00 AM EST

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Army Medical Resources Acq Activity

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → Army Medical Resources Acq Activity

Office AddressN/A

ContactsNo contact information available

Full Description

Conduct a U.S.-based Phase I/II clinical study to evaluate the safety, pharmacokinetics, and pharmacogenomics of tafenquine, including subject enrollment, dosing, blood sampling, and safety follow-up.